2017
DOI: 10.1039/c7mb00175d
|View full text |Cite
|
Sign up to set email alerts
|

Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design

Abstract: Stabilization of a G-quadruplex (G4) DNA structure in the proto-oncogene c-MYC using small molecule ligands has emerged as an attractive strategy for the development of anticancer therapeutics. To understand the subtle structural changes in the G4 structure upon ligand binding, molecular dynamics (MD) simulations of c-MYC G4 DNA were carried out in a complex with six different potent ligands: 3AQN, 6AQN, 3APN, 360A, Nap-Et, and Nap-Pr. The results show that the ligands 3AQN, 6AQN, 3APN, and 360A stabilize the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 67 publications
0
8
0
Order By: Relevance
“…The above results were obtained with the telomeric and the hTERT promoter sequences. However, G4 DNAs can be formed from DNA sequences found in the promoter region of several oncogenes, including c-Myc , VEGF , BCL-2 , c-KIT , c-MYB , HIF-1α , HRAS , KRAS , PDGF-A , PDGFR-β , RET , and SRC ; these sites are potential targets for anticancer therapy by G4 ligands. The structural variations of G4 are diverse, and specific G4 ligands can explicitly bind one topology, among others. , To investigate whether our three PDIs could differentially interact with different G4 DNAs at these three pHs (pH 6–8), we employed a duplex–quadruplex competition assay with two more sequences, the c-Myc promoter and VEGF promoter sequences. The results are shown in Figure S4, Supporting Information.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The above results were obtained with the telomeric and the hTERT promoter sequences. However, G4 DNAs can be formed from DNA sequences found in the promoter region of several oncogenes, including c-Myc , VEGF , BCL-2 , c-KIT , c-MYB , HIF-1α , HRAS , KRAS , PDGF-A , PDGFR-β , RET , and SRC ; these sites are potential targets for anticancer therapy by G4 ligands. The structural variations of G4 are diverse, and specific G4 ligands can explicitly bind one topology, among others. , To investigate whether our three PDIs could differentially interact with different G4 DNAs at these three pHs (pH 6–8), we employed a duplex–quadruplex competition assay with two more sequences, the c-Myc promoter and VEGF promoter sequences. The results are shown in Figure S4, Supporting Information.…”
Section: Resultsmentioning
confidence: 99%
“…33−35 The structural variations of G4 are diverse, and specific G4 ligands can explicitly bind one topology, among others. 34,36 To investigate whether our three PDIs could differentially interact with different G4 DNAs at these three pHs (pH 6−8), we employed a duplex−quadruplex competition assay with two more sequences, the c-Myc promoter and VEGF promoter sequences. The results are shown in Figure S4, Supporting Information.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Reasons for the differences between binding and function include the possibility that in vitro folded G4s differ structurally from those found in cells and lack accessory proteins that play a physiological role in G4 folding. 17,39,40 Moreover, our ALIS screen tested for binding to a prefolded G4 DNA sequence, and compounds that rely on the dynamic nature of these structures, or bind to other versions of the diversity of these structures were possibly missed. Different binding assays also may report different results, even for the same compound and folded G4, due to different assay conditions, such as solution-based versus immobilization-based screening; 41 this may be the case regarding the different G4-binding profiles that we observed for control A compared with published results using surface plasmon resonance (SPR).…”
Section: Discussionmentioning
confidence: 99%
“…In order to examine binding affinity of ligands to G-quadruplex, MM-PBSA analysis [49][50][51] was employed via g_mmpbsa tool [52]. For each complex, the binding free energy was calculated based on 100 snapshots extracted from the MD trajectory.…”
Section: Free Energy Analysismentioning
confidence: 99%